Angiotensin II for the Treatment of Vasodilatory Shock

Cited by (916)

Items 101–200 of 916

1. Association between dexmedetomidine administration and outcomes in critically ill patients with sepsis-associated acute kidney injury
   Hongbin Hu, Sheng li An, Tong Sha, Feng Wu, Yinghui Jin, Lulan Li, Zhenhua Zeng, Jie Wu, Zhongqing Chen · 2022 · Journal of Clinical Anesthesia
2. Fluid resuscitation in patients with cirrhosis and sepsis: A multidisciplinary perspective
   François Durand, John A. Kellum, Mitra K. Nadim · 2023 · Journal of Hepatology
3. Sepsis: An Update on Current Practices in Diagnosis and Management
   Snigdha Jain · 2018 · The American Journal of the Medical Sciences
4. Pathophysiology, mechanisms, and managements of tissue hypoxia
   Jihad Mallat, Nadeem Rahman, Fadi Hamed, Glenn Hernández P, Marc-Olivier Fischer · 2022 · Anaesthesia Critical Care & Pain Medicine
5. Association of Sublingual Microcirculation Parameters and Capillary Refill Time in the Early Phase of ICU Admission*
   Weipeng Huang, Hui Xiang, Chang Hu, Tong Wu, Dandan Zhang, Siqing Ma, Bo Hu, Jianguo Li · 2023 · Critical Care Medicine
6. A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
   Aditi Shankar, Gayathri Gurumurthy, Lakshmi Sridharan, Divya Gupta, William J. Nicholson, Wissam A. Jaber, Saraschandra Vallabhajosyula · 2022 · Clinical Medicine Insights Cardiology
7. Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
   Shiwani Kamath, Hiba Hammad Altaq, Tony Abdo · 2023 · Microorganisms
8. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
   Laurence W. Busse, Michael T. McCurdy, Osman Ali, Anna Hall, Huaizhen Chen, Marlies Ostermann · 2017 · Critical Care
9. Molecular mechanisms linking stress and insulin resistance
   Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar · 2021 · EXCLI journal
10. A double‐blind randomised feasibility trial of angiotensin‐2 in cardiac surgery *
    Tim G. Coulson, Lachlan Fraser Miles, Ary Serpa Neto, David V. Pilcher, Laurence Weinberg, Giovanni Landoni, Alexander Zarbock, Rinaldo Bellomo · 2022 · Anaesthesia
11. Biomarkers in sepsis
    Juhi Saxena, Sarvjeet Das, Anshu Kumar, Aditi Sharma, Lalit Kumar Sharma, Sanket Kaushik, Vijay Kumar Srivastava, Arif Jamal Siddiqui, Anupam Jyoti · 2024 · Clinica Chimica Acta
12. Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury
    Laurence W. Busse, Marlies Ostermann · 2019 · Seminars in Nephrology
13. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options
    Jamel P. Ortoleva, Alexander Daniel Shapeton, Matthew W. Vanneman, Adam A. Dalia · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
14. Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies
    Theresa J. Barnes, Maxwell A. Hockstein, Craig S. Jabaley · 2020 · SAGE Open Medicine
15. High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock
    Jayshil J. Patel, Rodney E. Willoughby, Jennifer Peterson, Thomas Carver, James Zelten, Adrienne Markiewicz, Kaitlin Spiegelhoff, Lauren A Hipp, Bethany Canales, Anikó Szabó et al. · 2022 · CHEST Journal
16. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients
    for the PRONOBURN group, François Dépret, Juliette Amzallag, Adrien Polina, Laure Fayolle-Pivot, Maxime Coutrot, Maïté Chaussard, Karine F. Santos, Oliver Hartmann, Marion Jully et al. · 2020 · Critical Care
17. COVID-19 and the cardiovascular system: an update
    Joshua Kuimeta Salabei, Zekarias T. Asnake, Zeeshan H. Ismail, Kipson Charles, Greg Stanger, Abdullah H. Abdullahi, Andrew T Abraham, Peters Okonoboh · 2022 · The American Journal of the Medical Sciences
18. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome
    Adam S. Evans, Michael T. McCurdy, Menachem M. Weiner, Bledi Zaku, Jonathan H. Chow · 2018 · The Annals of Thoracic Surgery
19. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Lakhmir S. Chawla, Marlies Ostermann, Lui G. Forni, George F. Tidmarsh · 2019 · Critical Care
20. Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions
    Olivier Lesur, Eugénie Delile, Pierre Asfar, Peter Radermacher · 2018 · Annals of Intensive Care
21. Multimodal strategy to counteract vasodilation in septic shock
    Marc Léone, Sharon Einav, Elio Antonucci, François Dépret, Inès Lakbar, Ignacio Martín‐Loeches, Patrick M. Wieruszewski, Sheila Nainan Myatra, Ashish Kumar Khanna · 2023 · Anaesthesia Critical Care & Pain Medicine
22. A PILOT STUDY OF ANGIOTENSIN II AS PRIMARY VASOPRESSOR IN CRITICALLY ILL ADULTS WITH VASODILATORY HYPOTENSION: THE ARAMIS STUDY
    Emily J. See, Caroline Clapham, Jasmine Liu, Monique Khasin, Grace M. Liskaser, Jian Wen Chan, Ary Serpa Neto, Rahul Costa Pinto, Rinaldo Bellomo · 2023 · Shock
23. Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
    the COVID-BioB Study Group, Alberto Zangrillo, Giovanni Landoni, Luigi Beretta, Federica Morselli, Ary Serpa Neto, Rinaldo Bellomo · 2020 · Critical Care
24. Cytokine signatures of end organ injury in COVID-19
    Luis G. Gómez-Escobar, Katherine L. Hoffman, Justin J. Choi, Alain Borczuk, Steven Salvatore, Sergio L. Alvarez-Mulett, Manuel D Galvan, Zhen Zhao, Sabrina Racine‐Brzostek, He S. Yang et al. · 2021 · Scientific Reports
25. Multi-Omics Techniques Make it Possible to Analyze Sepsis-Associated Acute Kidney Injury Comprehensively
    Jiao Qiao, Liyan Cui · 2022 · Frontiers in Immunology
26. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury
    Rafidah Atan, Leah Peck, John Richard Prowle, Elisa Licari, Glenn M. Eastwood, Markus Storr, Hermann Goehl, Rinaldo Bellomo · 2018 · Critical Care Medicine
27. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026
    Scott L. Weiss, Mark John Peters, Simon J. W. Oczkowski, Emilie P. Belley‐Côté, Corinne Buysse, Karen L. M. Choong, Akash Deep, David Philip Inwald, Heidi R. Flori, Martin C. J. Kneyber et al. · 2026 · Pediatric Critical Care Medicine
28. Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
    Antoine Herpain, Stefaan Bouchez, Massimo Girardis, Fabio Guarracino, Hans Knotzer, Bruno Lévy, Tobias Liebregts, Piero Pollesello, Sven‐Erik Ricksten, Hynek Říha et al. · 2018 · Journal of Cardiovascular Pharmacology
29. Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model
    Daniel E. Leisman, Jamie R. Privratsky, Jake R. Lehman, Mabel N. Abraham, Omar Y. Yaipan, Mariana R. Brewer, Ana Nedeljkovic-Kurepa, Christine Capone, Tiago Fernandes, Robert Griffiths et al. · 2022 · Proceedings of the National Academy of Sciences
30. The Burden of Sepsis and Septic Shock in the Intensive Care Unit
    Luigi La Via, Antonino Maniaci, Mario Lentini, Giuseppe Cuttone, Salvatore Ronsivalle, Simona Tutino, Francesca Maria Rubulotta, Giuseppe Nunnari, Andrea Marıno · 2025 · Journal of Clinical Medicine
31. Preadmission Antihypertensive Drug Use and Sepsis Outcome: Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)
    Ming‐Shun Hsieh, Chorng–Kuang How, Vivian Chia‐Rong Hsieh, Pau‐Chung Chen · 2019 · Shock
32. Reversal of Vasodilatory Shock: Current Perspectives on Conventional, Rescue, and Emerging Vasoactive Agents for the Treatment of Shock
    Jonathan H. Chow, Ezeldeen Abuelkasem, Susan K. Sankova, Reney A. Henderson, Michael A. Mazzeffi, Kenichi A. Tanaka · 2019 · Anesthesia & Analgesia
33. The Association Between Angiotensin II and Renin Kinetics in Patients After Cardiac Surgery
    Melanie Meersch, Raphael Weiss, Christina Massoth, Mira Küllmar, Khaschayar Saadat-Gilani, Manuel Busen, Lakhmir Chawla, Giovanni Landoni, Rinaldo Bellomo, Joachim Gerss et al. · 2022 · Anesthesia & Analgesia
34. Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026
    Scott L. Weiss, Mark John Peters, Simon J. W. Oczkowski, Emilie P. Belley‐Côté, Corinne Buysse, Karen L. M. Choong, Akash Deep, David Philip Inwald, Heidi R. Flori, Martin C. J. Kneyber et al. · 2026 · Intensive Care Medicine
35. Catecholaminergic Vasopressors Reduce Toll-Like Receptor Agonist-Induced Microvascular Endothelial Cell Permeability But Not Cytokine Production
    Jérémie Joffre, Elliot Lloyd, Erika Wong, Che Chung-Yeh, Nina Nguyen, Fenguyn Xu, Matthieu M. Legrand, Judith Hellman · 2021 · Critical Care Medicine
36. The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients
    Ishaq Lat, Craig M. Coopersmith, Daniel De Backer · 2021 · Critical Care Medicine
37. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
    Bruno Garcia, Benoit Ter Schiphorst, Karine F. Santos, Fuhong Su, Laurence Dewachter, Francisco Vasques‐Nóvoa, Estela Rocha-Oliveira, Roberto Roncon‐Albuquerque, Theo Ikenna Uba, Oliver Hartmann et al. · 2024 · Intensive Care Medicine Experimental
38. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
    Fortunato Fred Senatore, Gowraganahalli Jagadeesh, Martin Rose, Venkateswaran C. Pillai, Sudharshan Hariharan, Ququan Liu, Tzu‐Yun McDowell, Mohan K. Sapru, Mary Ross Southworth, Norman Stockbridge · 2018 · American Journal of Cardiovascular Drugs
39. A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy
    Jamel P. Ortoleva, Frederick C. Cobey · 2018 · Journal of Cardiothoracic and Vascular Anesthesia
40. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock
    Patrick M. Wieruszewski, Misty A. Radosevich, KIANOUSH B KASHANI, Richard C. Daly, Erica D. Wittwer · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
41. Kidney Dysfunction After Traumatic Brain Injury: Pathophysiology and General Management
    Greet De Vlieger, Geert Meyfroidt · 2022 · Neurocritical Care
42. Plasma Renin Concentration is Associated With Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock
    Maxime Nguyen, Damien Denimal, Auguste Dargent, Pierre‐Grégoire Guinot, Laurence Duvillard, Jean‐Pierre Quenot, Bélaïd Bouhemad · 2018 · Shock
43. Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence
    Alessandro Belletti, Giovanni Landoni, В. В. Ломиворотов, Alessandro Oriani, Silvia Ajello · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
44. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings
    Rajkumar Singh Kalra, Dhanendra Tomar, Avtar S. Meena, Ramesh J. L. Kandimalla · 2020 · Pathogens
45. Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides
    Adrien Picod, Sandrine Placier, Magali Genest, Jacques Callebert, Nathan Julian, Maxime Zalc, Noma Assad, Hugo Nordin, Karine F. Santos, Stèphane Gaudry et al. · 2024 · Hypertension
46. Angiotensin II in septic shock
    Amar P. Jadhav, Farid G. Sadaka · 2019 · The American Journal of Emergency Medicine
47. Drugs in Development for Acute Kidney Injury
    Matthew Hulse, Mitchell Howard Rosner · 2019 · Drugs
48. The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
    Matthieu M. Legrand, Ashish Kumar Khanna, Marlies Ostermann, Yuki Kotani, Ricard Ferrer, Massimo Girardis, Marc Léone, Gennaro De Pascale, Peter Pickkers, Pierre Tissières et al. · 2024 · Critical Care
49. Effect of early adjunctive vasopressin initiation for septic shock patients: a target trial emulation
    Kyle Christopher White, Rahul Costa‐Pinto, Sebastiaan Paul Blank, Stephen F. Whebell, Lachlan Quick, Stephen Luke, Antony George Attokaran, Peter Garrett, Mahesh Ramanan, Alexis Tabah et al. · 2025 · Critical Care
50. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock
    Gretchen L. Sacha, Simon W. Lam, Abhijit Duggal, Heather Torbic, Anita J Reddy, Seth R. Bauer · 2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
51. Vasoactive Agent Use in Septic Shock: Beyond First‐Line Recommendations
    Gretchen L. Sacha, Seth R. Bauer, Ishaq Lat · 2019 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
52. Association of Active Renin Content With Mortality in Critically Ill Patients: A Post hoc Analysis of the Vitamin C, Thiamine, and Steroids in Sepsis (VICTAS) Trial*
    Laurence W. Busse, Christopher L. Schaich, Mark C. Chappell, Michael T. McCurdy, Erin M. Staples, Caitlin ten Lohuis, Jeremiah S. Hinson, Jonathan Sevransky, Richard Eric Rothman, David W. Wright et al. · 2023 · Critical Care Medicine
53. ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock
    Daniel E. Leisman, Damian R. Handisides, Laurence W. Busse, Mark C. Chappell, Lakhmir S. Chawla, Michael R. Filbin, Marcia B. Goldberg, Kealy R. Ham, Ashish Kumar Khanna, Marlies Ostermann et al. · 2024 · Critical Care
54. Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise?
    Quentin Lajoye, Arthur Orieux, Alexandre Boyer, Renaud Prével, Mathieu Jozwiak · 2025 · Critical Care
55. A Pilot, Double-Blind, Randomized, Controlled Trial of High-Dose Intravenous Vitamin C for Vasoplegia After Cardiac Surgery
    Fumitaka Yanase, Laurent Bitker, Lara Hessels, E Osawa, Thummaporn Naorungroj, Salvatore Lucio Cutuli, Paul Jeffrey Young, Jay Ritzema, Georgia Hill, Charlotte Latimer-Bell et al. · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
56. Sepsis 2019: What Surgeons Need to Know
    Vanessa Phillis Ho, Haytham M. A. Kaafarani, Rishi Rattan, Nicholas Namias, Heather Leigh Evans, Tanya Liv Zakrison · 2019 · Surgical Infections
57. The surviving sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients
    Ishaq Lat, Craig M. Coopersmith, Daniel De Backer, Craig M. Coopersmith · 2021 · Intensive Care Medicine Experimental
58. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
    Bruno Garcia, Fuhong Su, Laurence Dewachter, Raphaël Favory, Amina Khaldi, Alexander Moiroux-Sahraoui, Filippo Annoni, Francisco Vasques‐Nóvoa, Estela Rocha-Oliveira, Roberto Roncon‐Albuquerque et al. · 2022 · Critical Care
59. MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock
    Francisco Vasques‐Nóvoa, Tiago L. Laundos, Rui João Cerqueira, Catarina Quina‐Rodrigues, Ricardo Soares-dos-Reis, Fabiana Baganha, Sara Ribeiro, Luís Mendonça, Francisco Gonçalves, Carlos Reguenga et al. · 2018 · Critical Care Medicine
60. Therapeutic approaches targeting renin-angiotensin system in sepsis and its complications
    Le Ning, Jiabing Rong, Zhaocai Zhang, Yinchuan Xu · 2021 · Pharmacological Research
61. A Multicenter Observational Cohort Study of Angiotensin II in Shock
    Susan Elizabeth Smith, Andrea S. Newsome, Yanglin Guo, Jason P. Hecht, Michael T. McCurdy, Michael A. Mazzeffi, Jonathan H. Chow, Shravan Kethireddy · 2020 · Journal of Intensive Care Medicine
62. Clinical trial design for unmet clinical needs: a spotlight on sepsis
    Jean‐Louis Vincent, Yasser L. Sakr · 2019 · Expert Review of Clinical Pharmacology
63. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
    Olga Papazisi, Meindert Palmen, A.H. Jan Danser · 2020 · Cardiovascular Drugs and Therapy
64. Angiotensin II: a new therapeutic option for vasodilatory shock
    Bussard RL, Laurence W. Busse · 2018 · Therapeutics and Clinical Risk Management
65. Vasoplegia: A Review
    Iqbal Ratnani, Rohan Kumar Ochani, Asim Shaikh, Hafsa Nazir Jatoi · 2023 · Methodist DeBakey Cardiovascular Journal
66. Vasopressin in Sepsis and Other Shock States: State of the Art
    Raquel García-Álvarez, Rafael Arboleda-Salazar · 2023 · Journal of Personalized Medicine
67. Angiotensin in ECMO patients with refractory shock
    Marlies Ostermann, David W. Boldt, Michael D. Harper, George W. Lim, Kyle J. Gunnerson · 2018 · Critical Care
68. Renal perfusion pressure: role and implications in critical illness
    Rakshit Panwar, Bairbre McNicholas, J. Pedro Teixeira, Amit Kansal · 2025 · Annals of Intensive Care
69. S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
    Frank Martin Brunkhorst, Michael Adamzik, Hubertus Axer, Michael W Bauer, Christian Bode, Hans-Georg Bone, Thorsten Brenner, Michael Bucher, Sascha David, Maximilian Dietrich et al. · 2025 · Medizinische Klinik - Intensivmedizin und Notfallmedizin
70. Vasopressor-Sparing Strategies in Patients with Shock: A Scoping-Review and an Evidence-Based Strategy Proposition
    Pierre‐Grégoire Guinot, Audrey Martin, Vivien Berthoud, Pierre Voizeux, Loïc Bartamian, Erminio Santangelo, Bélaïd Bouhemad, Maxime Nguyen · 2021 · Journal of Clinical Medicine
71. Angiotensin 1–7 in an experimental septic shock model
    Bruno Garcia, Fuhong Su, Francesca Manicone, Laurence Dewachter, Raphaël Favory, Amina Khaldi, Alexander Moiroux-Sahraoui, Anthony Moreau, Antoine Herpain, Jean‐Louis Vincent et al. · 2023 · Critical Care
72. Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review
    Mathieu Jozwiak, Guillaume Géri, Driss Laghlam, Kevin Boussion, Charles Dolladille, Lee S. Nguyen · 2022 · Frontiers in Medicine
73. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort
    Craig J. Furnish, Scott W. Mueller, Tyree Heath Kiser, Lisa Dufficy, Breandan Lawrence Sullivan, Jacob T. Beyer · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
74. Noradrenaline drives immunosuppression in sepsis: clinical consequences
    Roeland F. Stolk, Matthijs Kox, Peter Pickkers · 2020 · Intensive Care Medicine
75. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant
    Nathan S. Cutler, Bridget Rasmussen, Joseph F. Bredeck, Adrian L. Lata, Ashish Kumar Khanna · 2020 · Journal of Cardiothoracic and Vascular Anesthesia
76. Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19
    Chang Su, Zhenxing Xu, K. Hoffman, Parag Goyal, Monika M. Safford, Jerry S. H. Lee, Sergio L. Alvarez-Mulett, Luis G. Gómez-Escobar, David R. Price, John S. Harrington et al. · 2021 · Scientific Reports
77. Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial
    Tim G. Coulson, Lachlan Fraser Miles, Alex Zarbock, Louise M. Burrell, Sheila K. Patel, Thilo von Groote, David V. Pilcher, Laurence Weinberg, Giovanni Landoni, Rinaldo Bellomo · 2023 · British Journal of Anaesthesia
78. Expert consensus on blood pressure management in critically ill patients
    Yuetian Yu, Ye Gong, Bo Hu, Bin Ouyang, Aijun Pan, Jinglun Liu, Fen Liu, Xiuling Shang, Xianghong Yang, Guo-Wei Tu et al. · 2023 · Journal of Intensive Medicine
79. Critical Care Management of the Patient With Anaphylaxis: A Concise Definitive Review
    G. Krishnaswamy · 2021 · Critical Care Medicine
80. Hemodynamic Monitoring and Support
    Jean‐Louis Vincent, Alexandre Joosten, Bernd Saugel · 2021 · Critical Care Medicine
81. Vasopressors to treat refractory septic shock
    Zoé Meresse, Sophie Medam, Calypso Mathieu, Gary Duclos, Jean‐Louis Vincent, Marc Léone · 2020 · Minerva Anestesiologica
82. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock
    Mitchell S. Buckley, Jeffrey F. Barletta, Pamela L. Smithburger, John J. Radosevich, Sandra L. Kane‐Gill · 2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
83. Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting
    David Ragoonanan, Bryan Allen, Chad Cannon, Kathleen Rottman-Pietrzak, Abdel Bello · 2021 · Annals of Pharmacotherapy
84. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management
    Fortunato Fred Senatore, Pitchai Balakumar, Gowraganahalli Jagadeesh · 2021 · Pharmacological Research
85. Advances in understanding the role of angiotensin-regulated proteins in kidney diseases
    Ana Belen Sanz, Adrian Mario Ramos, María José Soler, María Dolores Sánchez-Niño, Beatriz Fernández‐Fernández, María Vanessa Pérez-Gómez, Marta Ruiz‐Ortega, Gloria Álvarez‐Llamas, Alberto Ortíz · 2018 · Expert Review of Proteomics
86. Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery
    Orlando R. Suero, Yangseon Park, Patrick M. Wieruszewski, Subhasis Chatterjee · 2023 · Critical Care Clinics
87. Current perspectives in the management of sepsis and septic shock
    Luis Chiscano‐Camón, Adolf Ruiz‐Sanmartín, Iván Bajaña, Juliana Bastidas, Rocío López‐Martínez, Clara Franco‐Jarava, Juan José González‐López, Nieves Larrosa, Jordi Riera, Xavier Nuvials et al. · 2024 · Frontiers in Medicine
88. Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers
    Khuraijam Dhanachandra Singh, Zaira Palomino Jara, Terri J. Harford, Prasenjit Prasad Saha, Triveni R. Pardhi, Russell W. Desnoyer, Sadashiva S. Karnik · 2021 · Proceedings of the National Academy of Sciences
89. Angiotensin II for the Treatment of Vasodilatory Shock
    Matthieu Jamme, Alexandre Hertig, Cédric Rafat · 2017 · New England Journal of Medicine
90. When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report
    Jonathan H. Chow, Samuel M. Galvagno, Kenichi A. Tanaka, Michael A. Mazzeffi, Zackary Chancer, Reney A. Henderson, Michael T. McCurdy · 2018 · A&A Practice
91. Sepsis Management for the Nephrologist
    Sharad Patel, Nitin Puri, Richard Phillip Dellinger · 2022 · Clinical Journal of the American Society of Nephrology
92. Alternatives to norepinephrine in septic shock: Which agents and when?
    Mathieu Jozwiak · 2022 · Journal of Intensive Medicine
93. Blood urea nitrogen to creatinine ratio is associated with in-hospital mortality among critically ill patients with cardiogenic shock
    Di Sun, Changmin Wei, Zhen Li · 2022 · BMC Cardiovascular Disorders
94. Angiotensin II for the Treatment of COVID-19–Related Vasodilatory Shock
    Jonathan H. Chow, Michael A. Mazzeffi, Michael T. McCurdy · 2020 · Anesthesia & Analgesia
95. Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Hyun Woo Lee, Jae Kyung Suh, Eun-Jin Jang, Sang‐Min Lee · 2020 · The Korean Journal of Internal Medicine
96. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery
    Troy G. Seelhammer, Daniel L. Plack, Scott D. Nei, Erica D. Wittwer, James Nelson, Christoph S. Nabzdyk · 2020 · Heart & Lung
97. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support
    Patrick M. Wieruszewski, Troy G. Seelhammer, Erin Frazee Barreto, Laurence W. Busse, Jonathan H. Chow, Danielle L Davison, Bhavita Gaglani, Ashish Kumar Khanna, Caitlin ten Lohuis, Kristin C. Mara et al. · 2022 · Journal of Intensive Care Medicine
98. Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial
    Fumitaka Yanase, Sofia Spano, Akinori Maeda, Anis Chaba, Thummaporn Naorungroj, Connie P. C. Ow, Yugeesh R. Lankadeva, Clive Newton May, Ashenafi Haileyesus Betrie, Darius J.R. Lane et al. · 2023 · Critical Care
99. Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review
    Irene Coloretti, Andrea Genovese, J. Pedro Teixeira, Anusha Cherian, Ricard Ferrer, Giovanni Landoni, Marc Léone, Massimo Girardis, Nathan D. Nielsen · 2024 · Journal of Anesthesia Analgesia and Critical Care
100. Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials
     Yuki Kotani, Alessandro Belletti, Filippo D’Amico, Alessandra Bonaccorso, Patrick M. Wieruszewski, Tomoko Fujii, Ashish Kumar Khanna, Giovanni Landoni, Rinaldo Bellomo · 2024 · Critical Care